Inactive Instrument

Farmak

FARM

UA4000099303

Farmak Seeks IPO By 2020

December 26, 2012 at 12:00 am

Farmak JSC said that it is planning Initial Public Offering (IPO) of shares by 2020. According to evaluation results, the company ended 2012 with a profit of UAH 279 million, Ukrainian News earlier reported.

Latest news about Farmak

Public Joint Stock Company "Farmak" acquired Symphar Sp Z O O.	03-27	CI
Public Joint Stock Company "Farmak" acquired Ukrainian business of Novator’s portfolio company from Novator Partners LLP.	23-05-31	CI
Public Joint Stock Company "Farmak" acquired Two pharmaceutical marketing companies in the Czech Republic and Slovakia of Novator.	23-05-31	CI
Altris, Inc announced that it has received $1 million in funding from a group of investors	22-12-13	CI
DrugCard announced that it has received €0.255 million in funding from Public Joint Stock Company "Farmak", Think Bigger Capital, SGEIC, S.A.	21-12-07	CI
Public Joint Stock Company "Farmak" Reports Earnings Results for the Nine Months Ended September 30, 2021	21-12-03	CI
ComeBack Mobility announced that it has received $1 million in funding from Fison, Public Joint Stock Company "Farmak", and other investors	21-06-29	CI
Public Joint Stock Company Farmak Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-28	CI
Bicovery announced that it has received $0.05 million in funding from Public Joint Stock Company "Farmak"	20-12-06	CI
ComeBack Mobility announced that it has received $0.13 million in funding from Public Joint Stock Company "Farmak" and other investors	20-12-06	CI
F.I.& P. Holdings Limited acquired additional 6.99% stake in Farmak JSC from Emer Group Limited.	19-01-30	CI
Emer Group acquired 6.99% stake in Farmak JSC from Foyil Capital Limited.	19-01-20	CI
Farmak Company Announces Board Changes	17-07-04	CI
Farmak International Holding GmbH sold 5.50% stake in Farmak Joint Stock Company.	17-02-02	CI
Farmak Announces Earnings Results for the Year 2015	16-03-01	CI
Farmak Announces Board Changes	15-02-24	CI
Farmak Group N.V. acquired 25% stake in Farmak Joint Stock Company from F.I.& P. Holdings Limited.	15-02-12	CI
The Farmak Group N.V acquired 41.8% stake in Farmak Joint Stock Company from F.I.& P. Holdings Limited and other shareholders.	14-03-19	CI
Farmak to Open Representative Office in Belarus	14-01-20	CI
Farmak Mulls Acquisitions	13-05-30	CI
Farmak International Holding GMBH acquired a 11.28% stake in Farmak JSC from Florian Overseas Investments Ltd.	13-02-11	CI
Farmak Seeks IPO By 2020	12-12-26	CI

Chart Farmak

Duration

Period

More charts

Company Profile

Farmak PAT (Farmak OJSC) is a Ukraine-based company involved in the chemical and pharmaceutical industry. The Company's product portfolio includes approximately 150 names in various dosage forms: parenteral dosage forms, drops, ointments, tablets and capsules. It is also involved in the production of pharmaceuticals for veterinarian use, pharmaceutical substances synthesis, contract manufacturing, and scientific research. The Company owns such facilities as equipment for labeling and packaging ampoules, production section for drags dosage forms of medicines, and a workshop for ointments, creams, pastes, and gels. Farmak PAT operates on the markets of Ukraine, the Baltic countries, Bulgaria, the Commonwealth of Independent States countries and Poland.

Sector

Pharmaceuticals

More about the company

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+25.40%	45.35B
OTSUKA HOLDINGS CO., LTD.	+37.49%	24.34B
SANDOZ GROUP AG	+27.12%	16.51B
CIPLA LIMITED	+21.19%	14.6B
ZYDUS LIFESCIENCES LIMITED	+71.91%	14.27B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-11.49%	6.57B
ASPEN PHARMACARE HOLDINGS LIMITED	+15.08%	5.76B
STADA ARZNEIMITTEL	-8.87%	5.73B

Generic Pharmaceuticals